RELIEF THERAPEUTICS Holding SA
Providing relief to patients with unmet medical needs in select specialty and rare diseases.
Providing relief to patients with unmet medical needs in select specialty and rare diseases.
RELIEF THERAPEUTICS Holding SA is a biopharmaceutical company based in Switzerland, committed to providing relief to patients with unmet medical needs in select specialty and rare diseases. Established in 2013, the company focuses on rare indications for metabolic disorders, pulmonary diseases, dermatology/connective tissue disorders, and genetic diseases. The firm's slogan encapsulates its dedication to delivering therapeutic relief to patients. In February 2024, Global Emerging Markets made a significant Fr.50.00M Post-IPO Equity investment in RELIEF THERAPEUTICS Holding SA, demonstrating investor confidence in the company's mission and potential. This investment signifies a pivotal moment in the company's growth trajectory, providing the necessary resources to drive advancements in treatment paradigms and deliver improvements in efficacy, safety, and convenience for patients and their families.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | Fr.50.00M | 1 |
|
28 Feb 2024 |
| Post-IPO Equity | Fr.5.00M | - | 16 Jun 2023 | |
| Post-IPO Equity | Fr.15.00M | - | 26 Jul 2021 | |
| Post-IPO Equity | Fr.10.00M | - | 12 Mar 2021 | |
| Series A | €2.50M | 1 |
|
24 May 2016 |
No recent news or press coverage available for RELIEF THERAPEUTICS Holding SA.
We care about your data, and we'd love to use cookies make your experience better.
